Central line infections in ICU patients
Part of Blood & lymphatic, Infections clinical trials.
This study is looking at infections from central lines (special IVs in large veins) in ICU patients across China. It aims to understand how common these infections are and what factors contribute to them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to be in the ICU with a central line (a special IV in a large vein) that will stay in for at least 48 hours.
- Your central line should have been placed either in the ICU or within the last 24 hours before you arrived.
- If you have been readmitted to the ICU during this stay, you cannot take part.
- You cannot be pregnant or breastfeeding.
- You must be willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new method to prevent infections from central lines (special IVs placed in large veins) in intensive care units. If you have a central line in place for more than 24 hours, this research may help improve your safety by finding better ways to avoid catheter-related bloodstream infections.
This study compares two types of central lines used in sick newborns: one placed in the belly button (UVC) and one placed in an arm or leg vein (PICC). It looks at which type is safer, lasts longer, and causes fewer bloodstream infections.
This study aims to reduce infections that can happen when you have a central line, which is a special tube placed in a large vein to give medicines or fluids. It will test ways to improve care for patients with these lines to prevent infections.
This study looks at ways to better treat central line infections that are hard to cure because of bacteria that stick to the tube. It may help find a treatment that works better for patients in intensive care.
This trial uses machine learning to predict infections that can happen with central lines (special IVs placed in large veins) and aims to reduce how often they occur. It focuses on hospitals with the highest infection rates, so you might be eligible if you receive care at one of these hospitals.
This study looks at whether taking blood cultures from an arterial line (a small tube in an artery) gives more accurate results and is less likely to have false positives compared to how blood is usually drawn. It may help improve how infections are detected in ICU patients.
Hear when a new CLABSI - Central Line Associated Bloodstream Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.